
Exagen XGN
$ 3.91
4.27%
Country |
|
IPO year |
2019 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
21.6 M |
Market Cap[1] |
$ 84.3 M |
EBITDA (LTM) |
$ -12 M |
P/E (LTM) |
-7.013333 |
P/S (LTM) |
1.568523 |
EPS (LTM) |
-0.75 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market | ||
|
DexCom
DXCM
|
$ 82.53 | 0.6 % | $ 32.2 B | Nasdaq Global Select Market,SPB | ||
|
Meridian Bioscience
VIVO
|
- | - | $ 1.49 B | Nasdaq Global Select Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Celcuity
CELC
|
$ 55.51 | -3.86 % | $ 2.6 B | Nasdaq Global Select Market | ||
|
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | ||
|
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Surmodics
SRDX
|
- | - | $ 608 M | Nasdaq Global Select Market,SPB | ||
|
Brainsway Ltd.
BWAY
|
$ 9.02 | -1.04 % | $ 306 M | Nasdaq Global Select Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | ||
|
Danaher Corporation
DHR
|
$ 228.43 | 1.18 % | $ 163 B | NYSE,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Anixa Biosciences
ANIX
|
$ 2.72 | 1.87 % | $ 88.3 K | Nasdaq Capital Market | ||
|
Biodesix
BDSX
|
$ 8.42 | -5.18 % | $ 63.6 M | Nasdaq Global Market | ||
|
Agilent Technologies
A
|
$ 176.32 | 2.38 % | $ 50.1 B | NYSE,SPB | ||
|
BioNano Genomics
BNGO
|
$ 0.98 | 3.13 % | $ 5.34 M | Nasdaq Capital Market,SPB | ||
|
Burning Rock Biotech Limited
BNR
|
$ 12.85 | 2.8 % | $ 135 M | Nasdaq Global Market | ||
|
Bioventus
BVS
|
$ 10.64 | 0.38 % | $ 709 M | Nasdaq Global Select Market | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 259.18 | 1.1 % | $ 28.8 B | NYSE,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 333.37 | 0.36 % | $ 16.5 B | NYSE,SPB | ||
|
Guardant Health
GH
|
$ 145.11 | 1.28 % | $ 18.2 B | Nasdaq Global Select Market,SPB | ||
|
Castle Biosciences
CSTL
|
$ 33.41 | 1.3 % | $ 968 M | Nasdaq Global Market,SPB | ||
|
Illumina
ILMN
|
$ 209.18 | 3.24 % | $ 32.4 B | Nasdaq Global Select Market,SPB | ||
|
IQVIA Holdings
IQV
|
$ 257.93 | 0.13 % | $ 44.3 B | NYSE,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 370.49 | 0.61 % | $ 30.8 B | NYSE,SPB | ||
|
IDEXX Laboratories
IDXX
|
$ 700.79 | 1.53 % | $ 56.4 B | Nasdaq Global Select Market,SPB | ||
|
Medpace Holdings
MEDP
|
$ 647.03 | -0.93 % | $ 18.7 B | Nasdaq Global Select Market,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 734.36 | 1.25 % | $ 35.7 B | NYSE,SPB | ||
|
Natera
NTRA
|
$ 286.77 | -0.25 % | $ 39.2 B | Nasdaq Global Select Market,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 102.03 | 0.23 % | $ 6.89 B | Nasdaq Global Select Market,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 25.14 | 3.84 % | $ 774 M | Nasdaq Global Market | ||
|
CareDx, Inc
CDNA
|
$ 74.4 | -0.21 % | $ 3.96 B | Nasdaq Global Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Biomerica
BMRA
|
$ 1.15 | -6.88 % | $ 3.35 M | Nasdaq Capital Market | ||
|
Interpace Biosciences
IDXG
|
$ 5.44 | -9.42 % | $ 24.1 M | Nasdaq Global Select Market | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
ICON Public Limited Company
ICLR
|
$ 194.96 | -0.03 % | $ 15.3 B | Nasdaq Global Select Market,SPB | ||
|
Senseonics Holdings
SENS
|
$ 9.76 | -3.99 % | $ 407 M | NYSE American | ||
|
Sotera Health Company
SHC
|
$ 16.27 | 1.34 % | $ 4.62 B | Nasdaq Global Select Market | ||
|
Co-Diagnostics
CODX
|
$ 0.2 | 1.99 % | $ 266 K | Nasdaq Capital Market | ||
|
Precipio
PRPO
|
$ 18.8 | -1.93 % | $ 30.2 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.